MAIN | ||
---|---|---|
OUTLOOK RATING 1..100 | 82 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 65 Fair valued | |
PROFIT vs RISK RATING 1..100 | 19 | |
SMR RATING 1..100 | 13 | |
PRICE GROWTH RATING 1..100 | 41 | |
P/E GROWTH RATING 1..100 | 32 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BDCZ | MAIN | |
---|---|---|
RSI ODDS (%) | 24 days ago89% | 3 days ago35% |
Stochastic ODDS (%) | 24 days ago88% | 3 days ago27% |
Momentum ODDS (%) | N/A | N/A |
MACD ODDS (%) | 24 days ago83% | 3 days ago44% |
TrendWeek ODDS (%) | 24 days ago77% | 3 days ago49% |
TrendMonth ODDS (%) | 24 days ago88% | 3 days ago58% |
Advances ODDS (%) | N/A | 8 days ago57% |
Declines ODDS (%) | 25 days ago78% | 25 days ago44% |
BollingerBands ODDS (%) | N/A | 3 days ago35% |
Aroon ODDS (%) | N/A | 3 days ago57% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HFERX | 47.12 | 0.29 | +0.62% |
Janus Henderson European Focus N | |||
CZMGX | 21.25 | 0.11 | +0.52% |
Multi-Manager Growth Strategies Inst | |||
PREFX | 77.33 | 0.36 | +0.47% |
T. Rowe Price Tax-Efficient Equity | |||
KMDIX | 30.34 | N/A | N/A |
Keeley Mid Cap Dividend Value I | |||
PHPIX | 26.63 | N/A | N/A |
ProFunds Pharmaceuticals UltraSector Inv |
A.I.dvisor tells us that BDCZ and MFIN have been poorly correlated (+19% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BDCZ and MFIN's prices will move in lockstep.
Ticker / NAME | Correlation To BDCZ | 1D Price Change % | ||
---|---|---|---|---|
BDCZ | 100% | +1.18% | ||
MFIN - BDCZ | 19% Poorly correlated | -0.94% | ||
HRZN - BDCZ | 12% Poorly correlated | +0.86% | ||
MAIN - BDCZ | 7% Poorly correlated | +1.37% | ||
GBDC - BDCZ | 5% Poorly correlated | +1.23% | ||
GAIN - BDCZ | 4% Poorly correlated | +1.36% | ||
More |